# Clario (BioClinica, Inc.) – FDA Inspection, Apr 12, 2024

Source: https://www.keypedia.com/records/fda_inspections/clario-bioclinica-inc/82f786ab-9938-4abf-8636-8da30b046912
Source feed: FDA_Inspections

> FDA inspection 1236873 of Clario (BioClinica, Inc.), April 12, 2024. Classification: No Action Indicated (NAI). 13 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1236873
- Company Name: Clario (BioClinica, Inc.)
- Inspection Date: 2024-04-12
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1334408 - 2026-08-18
- FDA Inspection 1330718 - 2026-07-30
- FDA Inspection 1325092 - 2026-06-25
- FDA Inspection 1318274 - 2026-04-22
- FDA Inspection 1314940 - 2026-02-23

## Related Officers

- [Sam Pepe](https://www.keypedia.com/people/sam-pepe/3e375dc5-b5af-4d79-a6f3-cded803aee7a)

Company: https://www.keypedia.com/companies/clario-bioclinica-inc/db385ee6-1af1-4a3f-8948-cf1ba22d7868

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c